insights_auto
Mtazamo: Thamani itaongezeka kwa asilimia 53.5·Thamani itapungua kwa asilimia 5.6
Nenda kwenye kichupo cha uchanganuzichevron_right
AMGN:NASDAQ
Amgen Inc
US$ 468.11
arrow_upward
+0.62%(+2.88) Siku 1
US$ 471.17
arrow_upward
+0.65% (+3.06)bedtimeBaada ya saa
Imefungwa: 11 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AMGN...
Fungua
US$ 460.98
Juu
US$ 468.46
Chini
US$ 459.14
Mtaji wa soko
253.21B
Wastani wa kiasi cha mauzo
2.76M
Kiasi cha mauzo ya hisa
0.00
Gawio
2.15%
Mgawo wa faida wa kila robo mwaka
US$ 2.52
Tarehe ya kutojumuisha gawio
20 Nov 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
27.14
Juu kwa wiki 52
US$ 483.99
Chini kwa wiki 52
US$ 312.53
EPS
US$ 17.25
Beta
0.43
Hisa za wawekezaji
540.91M
Idadi ya wafanyakazi
elfu 32
Fungua
US$ 460.98
Juu
US$ 468.46
Chini
US$ 459.14
Mtaji wa soko
253.21B
Wastani wa kiasi cha mauzo
2.76M
Kiasi cha mauzo ya hisa
0.00
Gawio
2.15%
Mgawo wa faida wa kila robo mwaka
US$ 2.52
Tarehe ya kutojumuisha gawio
20 Nov 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
27.14
Juu kwa wiki 52
US$ 483.99
Chini kwa wiki 52
US$ 312.53
EPS
US$ 17.25
Beta
0.43
Hisa za wawekezaji
540.91M
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
CoinMarketCap
·
saa 10 zilizopita
Amgen Inc tokenized stock (xStock) Price History and Historical Data
Investor's Business Daily
·
saa 11 zilizopita
How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever
Yahoo Finance
·
saa 16 zilizopita
Amgen (AMGN) Stock Looks Cheap Based On Future Cash Flow
Reuters
·
saa 16 zilizopita
Amgen's Sjogren's drug cuts disease activity in trial
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Kuhusu Amgen Inc
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa1980
Makao makuuThousand Oaks, California, Marekani
SektaHealth Care
Sekta-
Tovutiamgen.com